Press What’s news at AbelsonTaylor Group
Select category
Agency 100 Studio Session: AbelsonTaylor | The future of generative AI in pharma marketing
AT’s VP – Director of Engagement Strategy Sharlene Jenner discusses some of the opportunities and challenges generative AI will bring in the future of pharma marketing. Through this podcast, Sharlene discusses how marketers must bring their teams together to maximize the new technology, while also trying to gain a better understanding of privacy laws, and intellectual property protection.
Read more at MM+M Online.
Media Contact:
Recent Posts
Amy Restko Promoted to Vice President, Engagement Strategy at AbelsonTaylor Group
AbelsonTaylor Group today announced the promotion of Amy Restko to Vice President, Engagement Strategy. A strategic leader with expertise in...
Read Press Read more Amy Restko Promoted to Vice President, Engagement Strategy at AbelsonTaylor GroupCybersecurity considerations in pharma marketing: Trust must come first
“Responsible AI adoption is essential to protecting our clients, our agency, and the patients ultimately served by the work we...
In the News Read more Cybersecurity considerations in pharma marketing: Trust must come firstThe Leadership Circle: Kelly Ofman and the New Era of Pharma Communication
AbelsonTaylor Group’s current VP & Account Director analyzes the challenges of launching category-defining therapies, managing brands under global scrutiny, and...
In the News Read more The Leadership Circle: Kelly Ofman and the New Era of Pharma CommunicationConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.